Prime Medicine (PRME) Treasury Shares (2021 - 2025)
Prime Medicine's (PRME) quarterly Treasury Shares came in at $3.5 million in Q4 2025, little changed YoY from $3.5 million in Q4 2024, and little changed on a QoQ basis from $3.5 million in Q3 2025.
Prime Medicine (PRME) Treasury Shares (2021 - 2025) Analysis & Trends
Prime Medicine (PRME) has 5 years of Treasury Shares data on file, last reported at $3.5 million in Q4 2025.
- Quarterly Treasury Shares changed 0.0% year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.5 million (changed 0.0% YoY) and the FY2025 annual result came in at $3.5 million, changed 0.0% from the prior year.
- Treasury Shares was little changed at $3.5 million in Q4 2025, from $3.5 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $161.4 million in Q3 2022 to a low of $573394.0 in Q1 2024.
- A 5-year average of $32.9 million and a median of $3.5 million in 2024 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2023 — Treasury Shares tumbled 99.22% — and 2025, when it jumped 505.61%.
- Tracing PRME's Treasury Shares over 5 years: stood at $45.7 million in 2021, then plunged by 91.61% to $3.8 million in 2022, then slumped by 76.43% to $903227.0 in 2023, then soared by 284.46% to $3.5 million in 2024, then changed by 0.0% to $3.5 million in 2025.
- The last three Treasury Shares figures came in at $3.5 million (Q4 2025), $3.5 million (Q3 2025), and $3.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Prime Medicine | 558.48 Mn | 558.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.47 Mn |
| Dec 31, 2025 | 3.47 Mn |
| Sep 30, 2025 | 3.47 Mn |
| Sep 30, 2025 | 3.47 Mn |
| Jun 30, 2025 | 3.47 Mn |
| Jun 30, 2025 | 3.47 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Dec 31, 2024 | 3.47 Mn |
| Dec 31, 2024 | 3.47 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | 3.47 Mn |
| Mar 31, 2024 | 573,394.00 |
| Mar 31, 2024 | 573,394.00 |
| Dec 31, 2023 | 903,227.00 |
| Dec 31, 2023 | 903,227.00 |
| Sep 30, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.26 Mn |